e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Rare diffuse lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long term follow-up in patients with pulmonary alveolar proteinosis
Y. Ilkovich, L. Novikova, O. Baranova, I. Dvorakovskaya, A. Bazhanov (St. Petersburg, Russian Federation)
Source:
Annual Congress 2011 - Rare diffuse lung diseases
Session:
Rare diffuse lung diseases
Session type:
Thematic Poster Session
Number:
638
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Ilkovich, L. Novikova, O. Baranova, I. Dvorakovskaya, A. Bazhanov (St. Petersburg, Russian Federation). Long term follow-up in patients with pulmonary alveolar proteinosis. Eur Respir J 2011; 38: Suppl. 55, 638
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Related content which might interest you:
Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage
Source: International Congress 2017 – Paediatric bronchology
Year: 2017
Pulmonary alveolar proteinosis, study of 29 cases
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 220s
Year: 2001
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 526-531
Year: 2004
Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004
Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019
Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020
Year: 2020
Long clinical course of pulmonary alveolar microlithiasis in Japan
Source: Eur Respir J 2003; 22: Suppl. 45, 198s
Year: 2003
Pulmonary alveolar proteinosis: report of two cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008
Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009
Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011
Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child
Source: Eur Respir J 2003; 22: Suppl. 45, 309s
Year: 2003
Baseline characteristics of an Italian cohort of pulmonary alveolar proteinosis (PAP) patients
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017
The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept